An Update on Clinicopathological and Molecular Features of Plexiform Fibromyxoma

Table 3

Pathological and immunohistochemical profiles of PF cases reported in the literature.

No	Year	Author	Age	Sex	Ki-67	Vim	SMA	MSA	DOG-1	CD117	CD34	Desmin	Cald	S-100 protein	Calp	EMA	NF	CK	ER	PR	CD10	β-C	ALK	AE1/AE3	SNP	C-KIT	PDFGRA
1	2007	Takahashi	50	M	<1%	+	+	+		-	-	-	+/-	-			-	-				-				-	-
2	2007	Takahashi	68	M	<1%	+	+	+		-	-	-	+/-	-			-	-				-				-	-
3	2008	Galant	61	M		+	+			-	-	-		-		-
4	2008	Rau	50	F	2%		+	+		-	+/- (focal)	+/- (sporadic)		-								-	-			-	-
5	2008	Yoshida	19	F						-	-			-		-			-	-	-					-	-
6	2008	Yoshida	46	M	<1%		+	+		-	-	+/- (focal)	+ (partial)	-	+ (partial)									-		-	-
7	2009	Miettinen	38	F			+ (8/10)		-	-	-	-	- (3/3)	-							+ (1/3), -(2/3)			- (3/3)		wt (3/3)	wt (3/3)
8	2009	Miettinen	62	M					-	-	-	-		-
9	2009	Miettinen	75	F					-	-	-	-		-
10	2009	Miettinen	65	F					-	-	-	-		-
11	2009	Miettinen	33	M					-	-	-	-		-
12	2009	Miettinen	43	M					-	-	-	-		-
13	2009	Miettinen	56	F					-	-	-	-		-
14	2009	Miettinen	50	M					-	-	-	-		-
15	2009	Miettinen	21	M					-	-	-	-		-
16	2009	Miettinen	16	F					-	-	-	-		-
17	2009	Miettinen	30	F					-	-	-	-		-
18	2009	Miettinen	7	F					-	-	-	-		-
19	2009	Pailoor	23	F		+	+			-	-	+/- (partial)		-
20	2010	Sing	35	F	+		+	+		-	-	+	+	-	+				-	+	-	-	-	-
21	2010	Takahashi	23	M		+		+		-	-			-		-	-	-					-			-	-
22	2010	Tan	34	M	<2%		+			-	-	+		-												-	-
23	2010	Wang	54	F	<1%	+	+			-	-			-
24	2010	Cooper	64	M			+	+	-	-	-			-		-						-
25	2011	Kim	52	M			+			-		+/- (partial)		-
26	2012	Kang	47	M	6%		+			-	-	-		-		-	-
27	2012	Kang	63	F			+			-	-	-		-		-										wt	wt
28	2012	Schulz	59	M	<2%		+			-	-	-		-		-	-						-	-
29	2012	Cai	32	M			+	+		-	-			-
30	2012	Cai	47	F			+	+		-	-			-
31	2012	Wang	12	M			+	+	-	-	-			-
32	2012	Miettinen	49	F		+	+			-											+ (variably)
33	2012	Li	47	F	<1%		+			-	-		-	-								-	-
34	2012	Bi	31	M			+	+								+
35	2012	Bi	47	F			+	+
36	2012	Bi	42	F			+	+				+	+							+	+
37	2014	Baek	38	F			+			-	-			-
38	2014	Duckworth	16	F	1% (focally 8%)		+		-	-	-	-		-
39	2014	Duckworth	11	F		+	+			-	-	+		-	+								-	-	-
40	2014	Ikemura	27	F	Small Percentage		+			-	-	+/- (partial)							-	-	+
41	2014	Lee	42	F			+	+	-	-	-	-		-								-
42	2014	Li	32	M	<1%	+	+/- (partial)		-	-	-	+ (partial)	+ (partial)	-								-	-
43	2014	Sakamoto	60	M			-		-	-	-			-							-
44	2014	Li	73	F		+	+			-	-			-
45	2014	Tian	64	M			+		-	-	-
46	2015	Banerjee	19	F			-	-	-	-	-	-		-	-						-
47	2015	Fassan	55	F	0%	+	+	+		-	+	-		-		-					-					-	-
48	2015	Lu	26	F		+	+		-	-	-
49	2015	Ni	21	F	5%	+	+		-	-	-			-		-
50	2015	Wei	50	F			+		-					-
51	2015	Yue	34	M			+	+	-	-	-			-
52	2015	Yue	50	F			+	+	-	-	-			-
53	2015	Xu	50	F	<1%	+	+		-	-	-			-											-
54	2016	Dixit	51	F	<1%		+			-	-		-	-								-	-
55	2016	Inoue	36	F
56	2016	Jonaitis	28	F	40% (vascular endothelial Ki-67)		+				-	-		-
57	2016	Kane	28	F			+		-	-	-			-							+/- (focal)	-		-
58	2016	Morris	9	F			+		-	-	-	+/- (focal)		-	+			-			+/- (focal)		-
59	2016	Nagahisa	39	M			+			-	-			-
60	2016	Quero	47	M		+	+		-	-	-	+/- (partial)	+/- (partial)	-		-					+/- (partial)		-	+/- (focal)	-	wt	wt
61	2016	Spans	19	M			+			-	-	-		-									-
62	2016	Spans	65	F			+			-	-	-		-		-							-
63	2016	Spans	58	F			+			-	-	-		-		-							-
64	2016	Spans	51	F			+					+/- (focal)		-
65	2016	Spans	63	F			+					+/- (focal)		-
66	2016	Spans	76	F			+/- (focal)					+
67	2016	Spans	62	F								+/- (focal)		-
68	2016	Spans	30	F			+					+
69	2016	Spans	28	M			+				-	+/- (focal)		+									-
70	2016	Spans	44	F							+/- (focal)	+		-
71	2016	Spans	18	F			+/- (focal)					+/- (focal)
72	2016	Spans	19	F			+			-	-	-		-		-
73	2016	Spans	46	M			+				-	-		-
74	2016	Spans	29	M			+			-	-	-		-									-
75	2016	Spans	36	F			+			-	-	-		-
76	2016	Spans	47	F			+			-	-	-		-
77	2016	Li	11	M			+			-	-		+
78	2016	Zhang	48	M		+	+		-	-	-			-
79	2016	Li	44	F		+	-			-	+	-		-
80	2017	Akai	55	M		+	-			-	+	-		-
81	2017	Gonzalez-Cordero	37	M				+	-	-	-	+		-							+		-
82	2017	Hu	26	M		+	+		-	-	+/- (negative/focal)	+/- (patchy, 5/10)	+/- (patchy, 6/10)	-					-	+ (patchy/ diffusely at nucleus, 6/10)	+ (patchy, 5/10)		-			wt (5/10)	wt (5/10)
83	2017	Hu	31	F		+	+		-	-				-					-				-
84	2017	Hu	72	F		+	+		-	-				-					-				-
85	2017	Hu	59	F		+	+		-	-				-					-				-
86	2017	Hu	52	M		+	+		-	-				-					-				-
87	2017	Hu	59	F		+	+		-	-				-					-				-
88	2017	Hu	48	M		+	+		-	-				-					-				-
89	2017	Hu	58	M		+	+		-	-				-					-				-
90	2017	Hu	46	M		+	+		-	-				-					-				-
91	2017	Hu	40	F		+	+		-	-				-					-				-
92	2017	Kawara	66	M	2%		+ (focal)	+ (focal)	-	-	-	-	-	-	+ (focal)						-
93	2017	Kim	51	M			+			-
94	2017	Liang	11	M			+ (focal)		-	-	-	-	+ (focal)	-	+ (focal)								-
95	2017	Moris	63	M			+		-	-	-	-		-												wt	wt
96	2017	Qi	42	M	1%	+	+		-	-	-	+ (partial)	+ (partial)	-	+ (partial)	-					-			-
97	2017	Qi	66	M	1%	+	+		-	-	-			-		-					-			-
98	2017	Szurian	16	F			+		-	-	-	+ (focal)	+ (focal)	-							+/- (focal)	-	-			-	-
99	2017	Szurian	34	M			+		-	-	-	-	-	-							+/- (focal)	-	-
100	2017	Wambura	41	F			+		-	-		-		-							-
101	2017	Yang	50	F	3%	+	+		-	-	+	-		-		-		-			-	-	-
102	2017	Zhou	51	M	1%		+		-	-	-	-		-										-		-	-
103	2018	Djurić	14	M			+		-	-	-	+ (focal)		-			-						-
104	2018	Jang	47	F			+		-	-	-	+ (focal)		-		-					+ (focal)
105	2018	Rohit	81	F			+ (patchy)		-	-	-	-		-										-
106	2018	Wang	52	F	1%		+		-	-	-	-		+		-					+
107	2018	Zhang	31	F	<5%		+		-	-	-	-		-		-		-			+ (partial)
108	2019	Wu	59	F			+		-	-	-	+/- (focal)		-		-						-	-
109	2019	Fukazawa	14	F	2%	+	+		-	-	-	-		-									-
110	2019	Banerjee	65	M			+		-	-	-			-
111	2019	Lai	21	F			+			-	-	-		-
112	2019	Lai	42	F					-	-	-	-		-
113	2019	Lai	79	F	30%		+		-	-	-	+/- (focal)		-
114	2019	Lai	33	M			+			-	-	+/- (focal)		-
115	2019	Lai	60	M			+		-	-	-	+ (focal)		-
116	2019	Lai	77	M			+		-	-	-
117	2019	Lai	45	M			+		-	-	-
118	2019	Li	5	M		+	+		-	-	-	-		-								-

Abbreviations: Dx, diagnosis; Vim, vimentin; Cald, caldesmon; Calp, calponin; NF, neurofilament; CK, cytokeratin; β-C, β-catenin; SNP, synaptophysin; wt, wild type.